The Spread of Antibiotic Resistance Genes In Vivo Model

Shuan Tao1,2, Wei Liang2, Na Li3, Tong Wang4, Wei Liang1
1Lianyungang Clinical College of Jiangsu University, Lianyungang, Jiangsu Province, China
2School of Medical, Jiangsu University, Zhenjiang, Jiangsu Province, China
3Bengbu Medical College, Bengbu, Anhui Province, China
4Nanjing Brain Hospital Affiliated Nanjing Medical University, Nanjing, Jiangsu Province, China

Tóm tắt

Infections caused by antibiotic-resistant bacteria are a major public health threat. The emergence and spread of antibiotic resistance genes (ARGs) in the environment or clinical setting pose a serious threat to human and animal health worldwide. Horizontal gene transfer (HGT) of ARGs is one of the main reasons for the dissemination of antibiotic resistance in vitro and in vivo environments. There is a consensus on the role of mobile genetic elements (MGEs) in the spread of bacterial resistance. Most drug resistance genes are located on plasmids, and the spread of drug resistance genes among microorganisms through plasmid-mediated conjugation transfer is the most common and effective way for the spread of multidrug resistance. Experimental studies of the processes driving the spread of antibiotic resistance have focused on simple in vitro model systems, but the current in vitro protocols might not correctly reflect the HGT of antibiotic resistance genes in realistic conditions. This calls for better models of how resistance genes transfer and disseminate in vivo. The in vivo model can better mimic the situation that occurs in patients, helping study the situation in more detail. This is crucial to develop innovative strategies to curtail the spread of antibiotic resistance genes in the future. This review aims to give an overview of the mechanisms of the spread of antibiotic resistance genes and then demonstrate the spread of antibiotic resistance genes in the in vivo model. Finally, we discuss the challenges in controlling the spread of antibiotic resistance genes and their potential solutions.

Từ khóa


Tài liệu tham khảo

10.4103/2045-080x.186181

10.1093/femsre/fux053

10.3389/fmicb.2016.00173

10.1016/j.mib.2020.02.002

10.1016/j.tim.2020.05.011

10.1038/s41467-020-17278-2

10.1038/s41396-018-0275-x

10.1016/j.tim.2017.09.005

10.1186/s40168-019-0663-0

10.1042/ebc20160053

10.1038/s41598-017-04662-0

10.1128/aac.00014-16

10.1038/ismej.2017.42

10.1016/j.envint.2019.105007

10.1007/s00239-018-9836-x

10.1139/cjm-2018-0275

10.1038/s41579-021-00650-4

10.1016/j.scitotenv.2021.146009

10.1093/gbe/evx192

10.1038/s41467-021-22757-1

10.3389/fmicb.2018.02154

10.3389/fmicb.2020.00761

10.3390/genes11111239

10.1371/journal.pone.0208468

10.1128/cmr.00088-17

10.3389/fcimb.2017.00126

10.1016/j.ijantimicag.2018.01.023

10.3390/antibiotics11010040

10.1128/msphere.00853-20

10.1016/j.tim.2018.06.007

10.1038/s41396-021-01095-6

10.1073/pnas.1315278110

10.1016/j.mib.2021.09.009

10.1038/s41598-019-47423-x

10.3389/fmicb.2018.02365

10.1186/1471-2148-10-59

10.1371/journal.ppat.1007878

10.7717/peerj.12194

10.1038/s41426-018-0169-z

10.1093/femsre/fux007

10.1039/c9md00044e

10.1093/femsle/fnw211

10.1038/s41579-020-00506-3

10.1016/j.tim.2017.05.011

10.1073/pnas.1906958116

10.1038/nature12212

10.2147/idr.s48820

10.1155/2021/1490732

10.3389/fmicb.2020.00432

10.1093/jac/dkx131

10.3389/fmicb.2015.00864

10.1186/s40168-019-0670-1

10.4103/ijmr.ijmr_1979_17

10.1080/19490976.2020.1799654

10.1111/imr.12563

10.1038/s41522-021-00260-1

10.1186/s12864-016-3152-x

10.3109/1040841x.2013.804031

10.1073/pnas.1113246109

10.1038/s41551-019-0397-0

10.1186/s40168-018-0551-z

10.1038/mi.2016.75

10.3390/ijerph17207618

10.3390/microorganisms8101587

10.1080/19490976.2021.2022442

10.12688/f1000research.8468.1

10.1371/journal.ppat.1010167

10.1093/jac/dkr547

10.3201/eid1606.091671

10.1128/aac.50.2.596-599.2006

10.1080/21505594.2015.1135289

10.1007/s10565-018-09448-2

10.1093/jac/dkr198

10.1093/cid/civ191

10.1128/msphere.00464-19

10.4269/ajtmh.20-0258

10.1016/j.ygeno.2021.05.003

10.1111/j.1574-6968.2004.tb09614.x

10.1016/s1473-3099(11)70059-7

10.1007/s11356-013-1905-5

10.1080/03601234.2013.816611

10.1016/j.mib.2011.04.009

10.1016/j.tim.2013.11.001

10.1111/j.1574-6968.2009.01512.x

10.1007/s00248-015-0583-x

10.1111/mec.14255

10.1016/j.envpol.2021.116760

10.3389/fmicb.2017.02199

10.1016/j.aninu.2018.04.006

10.4081/ijfs.2019.7956

10.1016/s2542-5196(17)30182-1

10.3168/jds.2017-12939

10.3390/microorganisms4010012

10.24272/j.issn.2095-8137.2020.131

10.1089/mdr.2017.0198

10.1128/msphere.00329-20

10.1089/fpd.2020.2792

10.3389/fmicb.2020.00322

10.3390/ijms222312661

10.1371/journal.pone.0009836

10.1016/j.ecoenv.2020.110461

10.1136/bmjquality.u211706.w4738

10.1016/j.mib.2015.03.004

10.3389/fmicb.2015.00528

10.1128/mmbr.00044-12

10.1021/acssynbio.7b00254

10.1006/jmbi.1999.3493

10.1093/nar/gkp478

10.1093/nar/gkp1144

10.1111/1574-6968.12005

10.3389/fmicb.2016.00011

10.2147/idr.s247271

10.1128/msphere.00064-16

10.1371/journal.pone.0225131

10.1038/s41396-020-0623-5

10.3389/fcimb.2020.619763

10.1038/s41396-020-00860-3

10.1007/s00203-021-02595-x

10.1128/mbio.00227-10

10.2147/idr.s358248

10.1038/s41579-019-0204-7

10.1186/s12951-021-01132-8

10.1016/j.cell.2017.11.032

10.1038/s41564-020-0692-2

10.1146/annurev-genet-120417-031321

10.47391/JPMA.1331

10.3390/antibiotics9020049

10.1093/jac/dkab450

10.1038/nature14098

10.1016/j.msec.2016.12.125

10.1111/pbi.13383

10.1016/j.drup.2016.11.001

10.1186/s12941-019-0317-x

L. Tetsch, 2017, The adaptive bacterial immune system CRISPR-Cas and its therapeutic potential, Medizinische Monatsschrift fur Pharmazeuten, 40, 17

10.1016/j.ijantimicag.2018.09.017

10.3390/antibiotics10070756

10.1038/s41598-017-07584-z

10.1016/j.biortech.2014.08.079

10.1038/nrg3962

10.1038/s41579-020-00497-1

10.1016/j.plasmid.2017.04.002